Patent · US Active

c-Kit antibodies and uses thereof

US8552157B2 · kind B2 · utility

19Cited by

0References

8Claims

0Family size

Assignee

ImClone LLC · US

Inventors

Michael Amatulli · Brooklyn, US
Laura Ann Breen (nee Brennan) · New York, US
Keren Paz · Tenafly, US

Key dates

Filing date	May 3, 2012
Grant date	Oct 8, 2013
Priority date	—
Expiry date	Jun 18, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention is directed to antibodies that specifically bind to an extracellular domain of human c-Kit, pharmaceutical compositions comprising these antibodies, and their use in treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.